Teva to initiate third Phase III trial of oral laquinimod for the treatment of relapsing remitting multiple sclerosis Active Biotech, 8 Aug 2012 Accessed on 13 Aug 2012 from http://activebiotech.com/press-releases-1?pressurl=http://cws.huginonline.com/A/1002/PR/201208/1632576.xml. CommentRecommendBookmarkWatch